Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosis.
[Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis].
HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis.
The effect of fluoxetine on progression in progressive multiple sclerosis: a double-blind, randomized, placebo-controlled trial.
[Cavitary lesions in multiple sclerosis: Multicenter study on twenty patients.]
Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis.
Obstructive Sleep Apnea is an Under-Recognized and Consequential Morbidity in Multiple Sclerosis.
An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions.
Specialty drug spending trends among medicare and medicare advantage enrollees, 2007-11.
Test-retest reliability of four sensory measures in people with multiple sclerosis.
A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment.
Axon initial segment-associated microglia.
Anatomical Distribution of Cuprizone-Induced Lesions in C57BL6 Mice.
Multiparameter Flow Cytometric Assays to Quantify Effector and Regulatory T-Cell Function in Multiple Sclerosis.
Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.
Cutting Edge: AhR Is a Molecular Target of Calcitriol in Human T Cells.
Metaboreflex activity in multiple sclerosis patients.
The Potential Roles of Aquaporin 4 in Alzheimer's Disease.
Physical activity and pediatric multiple sclerosis: Developing a research agenda.
UNUSUAL CLINICAL CASES THAT MIMIC ACUTE DISSEMINATED ENCEPHALOMYELITIS.
Ventricular arrhythmia in a male MS patient on fingolimod.
Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1.
Migration and multiple sclerosis in immigrants from United Kingdom and Ireland to Australia: a reassessment. III: risk of multiple sclerosis in UKI immigrants and Australian-born in Hobart, Tasmania.
Peripheral (Seventh) Nerve Palsy and Multiple Sclerosis: A Diagnostic Dilemma - A Case Report.
Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.
Pages
« first
‹ previous
…
625
626
627
628
629
630
631
632
633
…
next ›
last »